Premenopause

• 

  Subject Areas on Research

  • A diagnostically useful histopathologic feature of endometrial polyp: the long axis of endometrial glands arranged parallel to surface epithelium. 
  • A flexible parametric model for combining current status and age at first diagnosis data. 
  • A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. 
  • A prospective study of weight gain after premenopausal hysterectomy. 
  • A review of osteoporosis management in younger premenopausal women. 
  • Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk. 
  • Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study. 
  • Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York. 
  • Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women. 
  • Associations between Personal Care Product Use Patterns and Breast Cancer Risk among White and Black Women in the Sister Study. 
  • Breast cancer. Clinical practice guidelines in oncology. 
  • Cardiovascular hemodynamics during stress in premenopausal versus postmenopausal women. 
  • Changes in hemodynamics and left ventricular structure after menopause. 
  • Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. 
  • Coconut oil is associated with a beneficial lipid profile in pre-menopausal women in the Philippines. 
  • Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy. 
  • Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass. 
  • Current status of endocrine therapy for metastatic breast cancer. 
  • Depressive symptoms, physical activity, and weight gain in premenopausal Latina and White women. 
  • Determinants of increased energy expenditure in HIV-infected women. 
  • Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use. 
  • Effect of hysterectomy with ovarian preservation on ovarian function. 
  • Epidemiology of basal-like breast cancer. 
  • Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. 
  • Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. 
  • High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. 
  • Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. 
  • Identification of progesterone receptor in human subcutaneous adipose tissue. 
  • Influence of cognitive eating restraint on total-body measurements of bone mineral density and bone mineral content in premenopausal women aged 18-45 y: a cross-sectional study. 
  • Influence of sex and hormone status on circulating natriuretic peptides. 
  • Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups. 
  • Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. 
  • Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development. 
  • Menopausal transition symptoms in midlife women living with fibromyalgia and chronic fatigue. 
  • Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients. 
  • Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study. 
  • Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women. 
  • Progesterone receptor activity in leiomyomatosis peritonealis disseminata. 
  • Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer. 
  • Reproductive factors and breast cancer risk among older women. 
  • Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. 
  • Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. 
  • Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials. 
  • Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis. 
  • Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. 
  • Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins. 
  • Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia. 
  • Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. 
  • Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. 
  • Symptom experience and self-care strategies among healthy, midlife African-American women. 
  • The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease. 
  • Thyroid hormones affect recovery from depression during antidepressant treatment. 
  • Vitamin D receptor alleles do not correlate with bone mineral density in premenopausal Caucasian women from the southeastern United States. 
  • Younger women with breast carcinoma have a poorer prognosis than older women. 
  • Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Moorman, Patricia Gripka, Professor in Family Medicine and Community Health, Duke Cancer Institute